Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Kidney Int
    September 2017
  1. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    >> Share

  2. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    >> Share

  3. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    >> Share

  4. LUCAS GM
    Association between hepatitis C virus and chronic kidney disease: heterogeneity begets heterogeneity.
    Kidney Int. 2017;92:546-548.
    >> Share

    August 2017
  5. REBHOLZ CM, Selvin E, Liang M, Ballantyne CM, et al
    Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.
    Kidney Int. 2017 Aug 30. pii: S0085-2538(17)30497.
    >> Share

  6. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2017 Aug 23. pii: S0085-2538(17)30467.
    >> Share

  7. WILLIAMS MJ, Sugatani T, Agapova OA, Fang Y, et al
    The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Kidney Int. 2017 Aug 23. pii: S0085-2538(17)30476.
    >> Share

  8. TOMLINSON JAP, Wheeler DC
    The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
    Kidney Int. 2017 Aug 11. pii: S0085-2538(17)30397.
    >> Share

  9. AUFRICHT C, Beelen R, Eberl M, Fischbach M, et al
    Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network.
    Kidney Int. 2017 Aug 8. pii: S0085-2538(17)30419.
    >> Share

  10. ROBERTS DM, Lea-Henry TN
    Simplifying the hemodialysis prescription in patients with ethylene glycol poisoning.
    Kidney Int. 2017;92:291-293.
    >> Share

  11. KAMAL F, Khan MA, Howden CW
    Proton pump inhibitors and chronic kidney disease.
    Kidney Int. 2017;92:515.
    >> Share

  12. WYATT CM, Drueke TB
    Vascular calcification in chronic kidney disease: here to stay?
    Kidney Int. 2017;92:276-278.
    >> Share

    July 2017
  13. SHINOZAKI Y, Furuichi K, Toyama T, Kitajima S, et al
    Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease.
    Kidney Int. 2017 Jul 26. pii: S0085-2538(17)30332.
    >> Share

  14. NAVANEETHAN SD, Schold JD, Jolly SE, Arrigain S, et al
    Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30327.
    >> Share

  15. RITTER C, Miller B, Coyne DW, Gupta D, et al
    Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30326.
    >> Share

  16. HARAMBAT J, Kunzmann K, Azukaitis K, Bayazit AK, et al
    Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Kidney Int. 2017 Jul 17. pii: S0085-2538(17)30330.
    >> Share

  17. GALSGAARD J, Persson F, Hansen TW, Jorsal A, et al
    Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Kidney Int. 2017 Jul 13. pii: S0085-2538(17)30310.
    >> Share

  18. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    >> Share

  19. KORATALA A, Malpartida FR
    Endophthalmitis complicating dialysis access infection.
    Kidney Int. 2017;92:270.
    >> Share

  20. TAKEUCHI T, Ohno H, Satoh-Takayama N
    Understanding the immune signature fingerprint of peritoneal dialysis-related peritonitis.
    Kidney Int. 2017;92:16-18.
    >> Share

  21. KETTELER M, Block GA, Evenepoel P, Fukagawa M, et al
    Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.
    Kidney Int. 2017;92:26-36.
    >> Share

  22. PERALTA CA, Estrella MM
    Preventive nephrology in the era of "I" evidence: should we screen for chronic kidney disease?
    Kidney Int. 2017;92:19-21.
    >> Share

    June 2017
  23. JUNO JA, Waruk JLM, Harris A, Mesa C, et al
    gammadelta T-cell function is inhibited in end-stage renal disease and impacted by latent tuberculosis infection.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30241.
    >> Share

  24. SUGAHARA M, Tanaka T, Nangaku M
    Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease.
    Kidney Int. 2017 Jun 24. pii: S0085-2538(17)30305.
    >> Share

  25. MARSHALL MR
    Measuring the patient response to dialysis therapy: hemodiafiltration and clinical trials.
    Kidney Int. 2017;91:1279-1282.
    >> Share

  26. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    >> Share

  27. ZHANG G, Saito R, Sharma K
    A metabolite-GWAS (mGWAS) approach to unveil chronic kidney disease progression.
    Kidney Int. 2017;91:1274-1276.
    >> Share

    May 2017
  28. PLANTINGA LC, King L, Patzer RE, Lea JP, et al
    Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality.
    Kidney Int. 2017 May 20. pii: S0085-2538(17)30228.
    >> Share

  29. LAI TS, Lee MH, Yang HI, You SL, et al
    High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.
    Kidney Int. 2017 May 20. pii: S0085-2538(17)30216.
    >> Share

  30. LEW QJ, Jafar TH, Talaei M, Jin A, et al
    Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.
    Kidney Int. 2017 May 18. pii: S0085-2538(17)30214.
    >> Share

  31. WILD MG, Wallston KA, Green JA, Beach LB, et al
    The Perceived Medical Condition Self-Management Scale can be applied to patients with chronic kidney disease.
    Kidney Int. 2017 May 18. pii: S0085-2538(17)30213.
    >> Share

  32. LIU X, Yu R, Sun L, Garibotto G, et al
    The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease.
    Kidney Int. 2017 May 12. pii: S0085-2538(17)30171.
    >> Share

  33. SUCCAR L, Pianta TJ, Davidson T, Pickering JW, et al
    Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
    Kidney Int. 2017 May 2. pii: S0085-2538(17)30170.
    >> Share

  34. KORATALA A, Chornyy V, Shukla AM, Kazory A, et al
    Tunneled dialysis catheters might receive "permanent resident" status after a while: a case for caution.
    Kidney Int. 2017;91:1259.
    >> Share

  35. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.
    >> Share

  36. DAVENPORT A
    More frequent hemodialysis does not effectively clear protein-bound azotemic solutes derived from gut microbiome metabolism.
    Kidney Int. 2017;91:1008-1010.
    >> Share

  37. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    >> Share

    April 2017
  38. FERGUSON TW, Tangri N, Tan Z, James MT, et al
    Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30156.
    >> Share

  39. LIN W, Zhang Q, Liu L, Yin S, et al
    Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor gamma reduces the progression of chronic kidney disease.
    Kidney Int. 2017 Apr 14. pii: S0085-2538(17)30158.
    >> Share

  40. ILIUTA IA, Lachance P, Ghannoum M, Begin Y, et al
    Prediction and validation of the duration of hemodialysis sessions for the treatment of acute ethylene glycol poisoning.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30151.
    >> Share

  41. MADSEN NL, Goldstein SL, Froslev T, Christiansen CF, et al
    Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30155.
    >> Share

  42. HOSHINO J, Larkina M, Karaboyas A, Bieber BA, et al
    Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30110.
    >> Share

  43. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    >> Share

  44. LAW BM, Wilkinson R, Wang X, Kildey K, et al
    Interferon-gamma production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30107.
    >> Share

  45. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    >> Share

  46. LI L, Lai EY, Luo Z, Solis G, et al
    Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30111.
    >> Share

  47. VERMA S, Bassily E, Jarmi T
    An extreme case of tumoral calcinosis in an end-stage renal disease patient.
    Kidney Int. 2017;91:991.
    >> Share

  48. IYASERE O, Brown EA
    Cognitive function before and after dialysis initiation in adults with chronic kidney disease-a new perspective on an old problem?
    Kidney Int. 2017;91:784-786.
    >> Share

  49. WYATT CM
    Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?
    Kidney Int. 2017;91:766-768.
    >> Share

  50. HEINE GH, Brandenburg V
    Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?
    Kidney Int. 2017;91:778-780.
    >> Share

    March 2017
  51. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    >> Share

  52. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    >> Share

  53. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    >> Share

  54. KITTISKULNAM P, Chertow GM, Carrero JJ, Delgado C, et al
    Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30082.
    >> Share

  55. ZHANG J, Friberg IM, Kift-Morgan A, Parekh G, et al
    Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30068.
    >> Share

  56. ALTMANN C, Ahuja N, Kiekhaefer CM, Andres Hernando A, et al
    Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30071.
    >> Share

  57. MORENA M, Jaussent A, Chalabi L, Leray-Moragues H, et al
    Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30040.
    >> Share

  58. GRACIOLLI FG, Neves KR, Barreto F, Barreto DV, et al
    The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30025.
    >> Share

  59. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    >> Share

  60. MCMAHON GM, Hwang SJ, Clish CB, Tin A, et al
    Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
    Kidney Int. 2017 Mar 14. pii: S0085-2538(17)30034.
    >> Share

  61. PORT FK, Robinson BM, McCullough KP, Morgenstern H, et al
    Predialysis blood pressure on survival in hemodialysis patients.
    Kidney Int. 2017;91:755-756.
    >> Share


  62. Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016;90:411
    Kidney Int. 2017;91:758.
    >> Share

  63. OHNO Y, Kanno Y, Takenaka T
    Letter regarding "Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness".
    Kidney Int. 2017;91:757.
    >> Share

    February 2017
  64. BAGSHAW SM, Wald R
    Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury.
    Kidney Int. 2017 Feb 17. pii: S0085-2538(16)30755.
    >> Share

  65. XING YF, Cai RM, Lin Q, Ye QJ, et al
    Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
    Kidney Int. 2017 Feb 16. pii: S0085-2538(16)30756.
    >> Share

  66. DEKKER MJ, Marcelli D, Canaud BJ, Carioni P, et al
    Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30710.
    >> Share

  67. WEBSTER P, Lightstone L, McKay DB, Josephson MA, et al
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30748.
    >> Share

  68. GAROFALO C, Borrelli S, Minutolo R, Chiodini P, et al
    A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30752.
    >> Share

  69. AL AZZI Y, Daleo J, Dube G
    To Be or not To Be: a rare cause of AKI in a renal allograft.
    Kidney Int. 2017;91:513.
    >> Share

    January 2017
  70. KURELLA TAMURA M, Vittinghoff E, Hsu CY, Tam K, et al
    Loss of executive function after dialysis initiation in adults with chronic kidney disease.
    Kidney Int. 2017 Jan 27. pii: S0085-2538(16)30701.
    >> Share

  71. HU MC, Shi M, Gillings N, Flores B, et al
    Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Kidney Int. 2017 Jan 25. pii: S0085-2538(16)30649.
    >> Share

  72. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    >> Share

  73. GARG AX, Suri RS, Eggers P, Finkelstein FO, et al
    Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
    Kidney Int. 2017 Jan 13. pii: S0085-2538(16)30647.
    >> Share

  74. SIRICH TL, Fong K, Larive B, Beck GJ, et al
    Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Kidney Int. 2017 Jan 12. pii: S0085-2538(16)30648.
    >> Share

  75. LIAO CT, Andrews R, Wallace LE, Khan MW, et al
    Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30640.
    >> Share

  76. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    >> Share

  77. ASSIS LV, Pereira ER, Sa CB, Guimaraes-Neto I, et al
    Right ventricular perforation by tunneled hemodialysis catheter.
    Kidney Int. 2017;91:255.
    >> Share

  78. WYATT CM
    A rose by any other name: is stage 3a chronic kidney disease really a disease?
    Kidney Int. 2017;91:6-8.
    >> Share

  79. CAPLIN B, Nitsch D
    Urinary biomarkers of tubular injury in chronic kidney disease.
    Kidney Int. 2017;91:21-23.
    >> Share

  80. HATTORI M
    Hemoglobin target in children with chronic kidney disease: valuable new information.
    Kidney Int. 2017;91:16-18.
    >> Share

    December 2016
  81. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    >> Share

  82. MATHEW RO, Bangalore S, Lavelle MP, Pellikka PA, et al
    Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.
    Kidney Int. 2016 Dec 28. pii: S0085-2538(16)30625.
    >> Share

  83. KESKAR V, McArthur E, Wald R, Harel Z, et al
    The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30618.
    >> Share

  84. MUNOZ MENDOZA J, Isakova T, Cai X, Bayes LY, et al
    Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30622.
    >> Share

  85. TRIPEPI G, Pannier B, D'Arrigo G, Mallamaci F, et al
    Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.
    Kidney Int. 2016 Dec 20. pii: S0085-2538(16)30611.
    >> Share

  86. EVENEPOEL P, Behets GJ, Viaene L, D'Haese PC, et al
    Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.
    Kidney Int. 2016 Dec 17. pii: S0085-2538(16)30607.
    >> Share

  87. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    >> Share

  88. SOLEIMANI A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, et al
    Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30592.
    >> Share

  89. CARRERO JJ, Grams ME, Sang Y, Arnlov J, et al
    Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30589.
    >> Share

  90. SCHELLINGER IN, Cordasic N, Panesar J, Buchholz B, et al
    Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30561.
    >> Share

  91. KIM CS, Bae EH, Ma SK, Kim SW, et al
    The Case | Seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient.
    Kidney Int. 2016;90:1389-1390.
    >> Share

  92. DAVIES SJ
    Normalizing the peritoneal dialysis dose-have we got it right?
    Kidney Int. 2016;90:1162-1163.
    >> Share

  93. FARRINGTON K, Davenport A
    Would prescribing target Kt dose adjusted for body surface area improve hemodialysis outcomes?
    Kidney Int. 2016;90:1160-1162.
    >> Share

  94. WALD R, Perl J
    Extended hours hemodialysis and survival: extended hours, extended evidence?
    Kidney Int. 2016;90:1155-1157.
    >> Share

  95. LEE MJ, Park JT, Park KS, Kwon YE, et al
    Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease.
    Kidney Int. 2016;90:1368-1376.
    >> Share

  96. WYATT CM, Spence JD
    Folic acid supplementation and chronic kidney disease progression.
    Kidney Int. 2016;90:1144-1145.
    >> Share

    November 2016
  97. VERVLOET M, Cozzolino M
    Vascular calcification in chronic kidney disease: different bricks in the wall?
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30553.
    >> Share

  98. TANAKA K, Watanabe T, Takeuchi A, Ohashi Y, et al
    Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Kidney Int. 2016 Nov 21. pii: S0085-2538(16)30541.
    >> Share

  99. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    >> Share

  100. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    >> Share

  101. ELRGGAL ME, Kotb GA, Elghitani A, Zyada R, et al
    Coronary revascularization in chronic kidney disease patients, external validity of meta-analysis results.
    Kidney Int. 2016;90:1131-1132.
    >> Share

    October 2016
  102. HSU CY, Xie D, Waikar SS, Bonventre JV, et al
    Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30486.
    >> Share

  103. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    >> Share

  104. MADUELL F, Ramos R, Varas J, Martin-Malo A, et al
    Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk.
    Kidney Int. 2016 Oct 22. pii: S0085-2538(16)30469.
    >> Share

  105. BROWN EA, Finkelstein FO, Iyasere OU, Kliger AS, et al
    Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils?
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30474.
    >> Share

  106. GEWIN L, Zent R, Pozzi A
    Progression of chronic kidney disease: too much cellular talk causes damage.
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30473.
    >> Share

  107. BANSAL N, McCulloch CE, Lin F, Robinson-Cohen C, et al
    Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease.
    Kidney Int. 2016 Oct 4. pii: S0085-2538(16)30436.
    >> Share

  108. GRAHAM-BROWN MP, March DS, Churchward DR, Stensel DJ, et al
    Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Kidney Int. 2016;90:835-44.
    >> Share

  109. SHROFF GR, Raggi P
    Exploring the elusive link between subclinical fibrosis and clinical events in end-stage renal disease: does cardiac magnetic resonance imaging hold the key?
    Kidney Int. 2016;90:729-32.
    >> Share

  110. YADAV AK, Kumar V, Sinha N, Jha V, et al
    APOL1 risk allele variants are absent in Indian patients with chronic kidney disease.
    Kidney Int. 2016;90:906-7.
    >> Share

  111. VAN EERDE AM, Krediet CT, Rookmaaker MB, van Reekum FE, et al
    Pre-pregnancy advice in chronic kidney disease: do not forget genetic counseling.
    Kidney Int. 2016;90:905-6.
    >> Share

    September 2016
  112. TAMPE B, Steinle U, Tampe D, Carstens JL, et al
    Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30428.
    >> Share

  113. ZHANG Q, Liu L, Lin W, Yin S, et al
    Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30426.
    >> Share

  114. MATSUSHITA K, Chen J, Sang Y, Ballew SH, et al
    Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30429.
    >> Share

  115. SUGATANI T, Agapova OA, Fang Y, Berman AG, et al
    Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30425.
    >> Share

  116. SOTO K, Campos P, Pinto I, Rodrigues B, et al
    The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury.
    Kidney Int. 2016 Sep 19. pii: S0085-2538(16)30356.
    >> Share

  117. EL-KATEB S, Sridharan S, Farrington K, Fan S, et al
    A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30400.
    >> Share

  118. AMARAL S, Sayed BA, Kutner N, Patzer RE, et al
    Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30401.
    >> Share

  119. EVENEPOEL P, Bover J, Torres PU
    Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30402.
    >> Share

  120. DONG J, Dong Y, Chen Z, Mitch WE, et al
    The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30404.
    >> Share

  121. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    >> Share

  122. MARSHALL MR
    Observations of twice a week hemodialysis.
    Kidney Int. 2016 Sep 16. pii: S0085-2538(16)30380.
    >> Share

  123. HANNEDOUCHE T, Roth H, Krummel T, London GM, et al
    Multiphasic effects of blood pressure on survival in hemodialysis patients.
    Kidney Int. 2016;90:674-84.
    >> Share

    August 2016
  124. CHEIKH HASSAN HI, Tang M, Djurdjev O, Langsford D, et al
    Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality.
    Kidney Int. 2016 Aug 30. pii: S0085-2538(16)30350.
    >> Share

  125. KIENEKER LM, Bakker SJ, de Boer RA, Navis GJ, et al
    Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease.
    Kidney Int. 2016 Aug 26. pii: S0085-2538(16)30349.
    >> Share

  126. RIVARA MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, et al
    Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30322.
    >> Share

  127. MATHEW A, Obi Y, Rhee CM, Chen JL, et al
    Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30299.
    >> Share

  128. CEJKA D, Parada-Rodriguez D, Pichler S, Marculescu R, et al
    Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30308.
    >> Share

  129. RUTHERFORD E, Talle MA, Mangion K, Bell E, et al
    Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Kidney Int. 2016 Aug 5. pii: S0085-2538(16)30298.
    >> Share

  130. BRIER ME, Gaweda AE
    Artificial intelligence for optimal anemia management in end-stage renal disease.
    Kidney Int. 2016;90:259-61.
    >> Share

  131. MORADI H, Said HM
    Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients.
    Kidney Int. 2016;90:252-4.
    >> Share

  132. CHEN TK, Estrella MM
    APOL1 risk variants and death among African American hemodialysis patients: survival of the fittest?
    Kidney Int. 2016;90:249-52.
    >> Share

  133. RIGATTO C, Komenda P, Tangri N
    CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?
    Kidney Int. 2016;90:257-9.
    >> Share

    July 2016
  134. SINGH S, Grabner A, Yanucil C, Schramm K, et al
    Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
    Kidney Int. 2016 Jul 22. pii: S0085-2538(16)30236.
    >> Share

  135. CARLSEN RK, Peters CD, Khatir DS, Laugesen E, et al
    Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness.
    Kidney Int. 2016 Jul 8. pii: S0085-2538(16)30205.
    >> Share

  136. HU YW
    Chinese herbal medicine use and risk of end-stage renal disease in patients with chronic kidney disease: is there an immortal time bias?
    Kidney Int. 2016;90:227-8.
    >> Share

  137. WYATT CM, Cattran DC
    Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
    Kidney Int. 2016;90:8-10.
    >> Share

  138. DE RECHTER S, Levtchenko E, Evenepoel P, Mekahli D, et al
    The Case | Hypercalcemia in a child with chronic kidney disease.
    Kidney Int. 2016;90:233-4.
    >> Share

    June 2016
  139. WEIR MR, Bakris GL, Gross C, Mayo MR, et al
    Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Kidney Int. 2016 Jun 24. pii: S0085-2538(16)30186.
    >> Share

  140. HALLAN SI, Ovrehus MA, Romundstad S, Rifkin D, et al
    Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30170.
    >> Share

  141. ZHOU Q, Bajo MA, Del Peso G, Yu X, et al
    Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Kidney Int. 2016 Jun 7. pii: S0085-2538(16)30138.
    >> Share

  142. BARBIERI C, Molina M, Ponce P, Tothova M, et al
    An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Kidney Int. 2016 Jun 2. pii: S0085-2538(16)30132.
    >> Share

  143. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.
    >> Share

  144. WHEELER DC, Kasiske BL
    Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study.
    Kidney Int. 2016;89:1189-91.
    >> Share

  145. JESUDASON D, Clifton P
    Limitations of using the Chronic Kidney Disease-Epidemiology Collaboration equation for measuring renal function in obese populations.
    Kidney Int. 2016;89:1400-1.
    >> Share

  146. HAGE V, Pelletier S, Fouque D
    No apparent link between serum Klotho and phosphate in human chronic kidney disease.
    Kidney Int. 2016;89:1399-400.
    >> Share

  147. ENDRE ZH, Fernando M
    Unlocking the code: mining the urinary proteome after renal transplantation.
    Kidney Int. 2016;89:1183-5.
    >> Share

  148. MASSY ZA, Drueke TB
    Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?
    Kidney Int. 2016;89:1180-2.
    >> Share

  149. WYATT CM, Shineski M, Chertow GM, Bangalore S, et al
    ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
    Kidney Int. 2016;89:1178-9.
    >> Share

    May 2016
  150. CHARYTAN DM, Desai M, Mathur M, Stern NM, et al
    Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Kidney Int. 2016 May 31. pii: S0085-2538(16)30126.
    >> Share

  151. ZHANG F, Masania J, Anwar A, Xue M, et al
    The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30057.
    >> Share

  152. MATHEW AT, Fishbane S, Obi Y, Kalantar-Zadeh K, et al
    Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
    Kidney Int. 2016 May 12. pii: S0085-2538(16)30054.
    >> Share

  153. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    >> Share

  154. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    >> Share

  155. SALAND JM, Satlin LM, Zalsos-Johnson J, Cremers S, et al
    Impaired postprandial lipemic response in chronic kidney disease.
    Kidney Int. 2016 May 7. pii: S0085-2538(16)30011.
    >> Share

  156. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    >> Share

  157. CARRERO JJ, Johansen KL, Lindholm B, Stenvinkel P, et al
    Screening for muscle wasting and dysfunction in patients with chronic kidney disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30003.
    >> Share

    April 2016
  158. CHESNAYE NC, Schaefer F, Groothoff JW, Bonthuis M, et al
    Mortality risk in European children with end-stage renal disease on dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00366.
    >> Share

  159. NEU AM, Richardson T, Lawlor J, Stuart J, et al
    Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00365.
    >> Share

  160. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    >> Share

  161. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    >> Share

    March 2016
  162. CARRILLO-LOPEZ N, Panizo S, Alonso-Montes C, Roman-Garcia P, et al
    Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Kidney Int. 2016 Mar 24. pii: S0085-2538(16)00314.
    >> Share

  163. AGAPOVA OA, Fang Y, Sugatani T, Seifert ME, et al
    Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.
    Kidney Int. 2016 Mar 11. pii: S0085-2538(16)00290.
    >> Share

  164. SIGDEL TK, Gao Y, He J, Wang A, et al
    Mining the human urine proteome for monitoring renal transplant injury.
    Kidney Int. 2016 Mar 4. pii: S0085-2538(16)00288.
    >> Share

    February 2016
  165. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    >> Share

  166. TAN BK, Yu Z, Fang W, Lin A, et al
    Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients.
    Kidney Int. 2016;89:487-97.
    >> Share

  167. JING YJ, Ni JW, Ding FH, Fang YH, et al
    p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/- mice.
    Kidney Int. 2016;89:439-49.
    >> Share

    January 2016
  168. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    >> Share

  169. SELAMET U, Tighiouart H, Sarnak MJ, Beck G, et al
    Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.
    Kidney Int. 2016;89:176-84.
    >> Share

  170. DAVENPORT A, Peters SA, Bots ML, Canaud B, et al
    Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size.
    Kidney Int. 2016;89:193-9.
    >> Share

    July 2015
  171. RABASCO C, Cavero T, Roman E, Rojas-Rivera J, et al
    Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
    Kidney Int. 2015 Jul 29. doi: 10.1038/ki.2015.
    >> Share

  172. CAMPBELL SB, Clayton PA
    A scoring system to screen elderly potential kidney transplant recipients: a simple tool for a complex task.
    Kidney Int. 2015;88:5-6.
    >> Share

    June 2015
  173. BERTHELOT L, Robert T, Vuiblet V, Tabary T, et al
    Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Kidney Int. 2015 Jun 10. doi: 10.1038/ki.2015.
    >> Share

    May 2015
  174. SIM JJ, Bhandari SK, Shi J, Reynolds K, et al
    Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
    Kidney Int. 2015 May 6. doi: 10.1038/ki.2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016